Gapping down
In reaction to disappointing earnings/guidance: BSPM -8.1%, CVV -2.1%, ESLT -1.7%, JASO -1.1%
Select notable EU names showing weakness: PHG -2.3%, DEG -2.3%, SAN -2%, DB -1.9%, UN -1.8%, STM -0.6%, HSBC -0.6%
Select oil/gas related names showing early weakness: SHI -2%, TOT -1.4%, RDS.A -1.1%
Other news: EBIO -71.6% (announces top-line results from its Phase 3 study of EBI-005; study did not achieve primary endpoints), BHP -5.1% (announces the commencement of trading of spin-off South 32; IPO launch generally perceived as disapointing valuation), NBG -4.3% (Greek banks trade lower today; IMF concerns Greece wont be able to make June 5 payment), OCN -4.3% (Reduced positions according to 13F filings at Highfield Cap and Alden Global), MT -2.9% (may be in symp with BHP), CLRB -2.6% (discloses a delay in filing form 10-Q), YGE -2.4% (still checking, co did file annual rpt Form 20-F), AZN -1% (reports MOVANTIKTM safety analyses of Opioid; also to invest ~$285 mln in a new high-tech facility for manufacturing of biological medicines in Sweden), BABA -1% (USA Today details news that Kering (PPRUY) has filed lawsuit against Alibaba (BABA) over counterfeit goods)
Analyst comments: YELP -1.9% (downgraded to Neutral from Overweight at Piper Jaffray), LINE -1.7% (downgraded to Sell from Neutral at Goldman), STO -1.7% (downgraded to Sell at Goldman), LYG -1.6% (downgraded to Sell at Investec), LVS -1.2% (downgraded to Neutral from Buy at Goldman), CTXS -1% (downgraded to Neutral from Buy at Goldman), GPOR -1% (downgraded to Sell from Neutral at Goldman), BP -0.9% (downgraded to Sell at Goldman), RRC -0.8% (downgraded to Neutral at Goldman), CVX -0.7% (downgraded to Sell from Neutral at Goldman), NGLS -0.6% (downgraded to Sell from Buy at Goldman), CHK -0.5% (downgraded to Neutral from Buy at Goldman)